Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in Huntington's disease.

C A Gutekunst1, F Norflus, S M Hersch

  • 1Department of Neurology, Emory University School of Medicine, Atlanta GA 30322, USA. mguteku@emory.edu

Current Opinion in Neurology
|September 2, 2000
PubMed
Summary

Huntington's disease, a fatal neurological disorder, stems from a genetic mutation. New models offer insights into its mechanisms and potential therapies for this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complex spatial and temporally defined myelin and axonal degeneration in Huntington disease.

NeuroImage. Clinical·2018
Same author

CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion.

Neurology·2012
Same author

Neuroprotective therapy for Huntington's disease: new prospects and challenges.

Expert review of neurotherapeutics·2009
Same author

Repeat instability in the 27-39 CAG range of the HD gene in the Venezuelan kindreds: Counseling implications.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics·2008
Same author

Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG.

Neurology·2006
Same author

Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease.

Proceedings of the National Academy of Sciences of the United States of America·2005

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Huntington's disease (HD) is a progressive, fatal neurodegenerative disorder.
  • HD is caused by a CAG trinucleotide repeat expansion in the huntingtin gene.
  • The precise mechanisms of neuronal death in HD remain unclear.

Purpose of the Study:

  • To explore the pathogenesis of Huntington's disease.
  • To investigate the role of mutant huntingtin in neuronal death.
  • To identify potential therapeutic targets for HD.

Main Methods:

  • Utilized novel animal and cell models of Huntington's disease.
  • Investigated the link between energy metabolism defects, oxidative stress, excitotoxicity, and apoptosis.
  • Examined the function of the huntingtin protein.

Related Experiment Videos

Main Results:

  • New models provide valuable insights into HD pathogenesis.
  • The study highlights the potential involvement of energy metabolism dysfunction and oxidative stress.
  • The exact mechanisms by which mutant huntingtin leads to neuronal death are still under investigation.

Conclusions:

  • Novel models are crucial for understanding Huntington's disease.
  • Further research is needed to elucidate the precise molecular mechanisms driving neurodegeneration in HD.
  • These findings pave the way for developing effective Huntington's disease therapies.